Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$66.29
-4.97-6.97%
At close: -
$68.83
2.543.83%
After Hours: Nov 15, 6:00 PM EDT
Comments
Loading...
Insmed (NASDAQ:INSM) Stock, Analyst Ratings, Price Targets, Forecasts
Insmed Inc has a consensus price target of $77.5 based on the ratings of 20 analysts. The high is $105 issued by Truist Securities on November 1, 2024. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by Truist Securities, HC Wainwright & Co., and Truist Securities on November 1, 2024, November 1, 2024, and October 11, 2024, respectively. With an average price target of $98.33 between Truist Securities, HC Wainwright & Co., and Truist Securities, there's an implied 42.86% upside for Insmed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
HC Wainwright & Co.
B of A Securities
JP Morgan
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Insmed
Data brought to you by Benzinga APIs
FAQ
What is the target price for Insmed (INSM) stock?
The latest price target for Insmed (NASDAQ:INSM) was reported by Truist Securities on November 1, 2024. The analyst firm set a price target for $105.00 expecting INSM to rise to within 12 months (a possible 52.55% upside). 50 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insmed (INSM)?
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by Truist Securities, and Insmed reiterated their buy rating.
When was the last upgrade for Insmed (INSM)?
There is no last upgrade for Insmed
When was the last downgrade for Insmed (INSM)?
There is no last downgrade for Insmed.
When is the next analyst rating going to be posted or updated for Insmed (INSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on November 1, 2024 so you should expect the next rating to be made available sometime around November 1, 2025.
Is the Analyst Rating Insmed (INSM) correct?
While ratings are subjective and will change, the latest Insmed (INSM) rating was a reiterated with a price target of $100.00 to $105.00. The current price Insmed (INSM) is trading at is $68.83, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.